AskNiveshWeekend·19:35 IST
  • Stocks
  • ·
  • Funds
  • ·
  • Signals

AskNivesh is a research desk for Indian markets, US equities, fund data, and disclosure trails. Built for investors who want source-backed context without the noise.

Market

  • Overview
  • Stocks
  • Indexes
  • Sectors
  • ETFs
  • Funds
  • IPOs

US Market

  • Political Trades
  • Disclosure Leaderboard
  • Politicians
  • Consensus Trades
  • Late Disclosures
  • Sector Tilt
  • US Stocks

Market Pulse

  • Market Pulse
  • Global Markets
  • Signals
  • FII DII Activity
  • Corporate Actions
  • RBI Macro
  • Derivatives
  • Currency Derivatives
  • Index Derivatives
  • Commodity Derivatives
  • F&O Expiries

Data

  • Glossary
  • Methodology
  • Analysis Methods
  • Technical Analysis
  • Candle Patterns
  • Brokers
  • Depositories
  • SEBI Intermediaries
  • Exchange Holidays
  • Global Investing
  • Sitemap

Company

  • About Us
  • Contact

Legal

  • Terms and Conditions
  • Privacy Policy
  • Disclaimer
  • Methodology
  • ·Glossary
  • ·Sitemap
  • ·Contact
Browse stocks by letter
AllABCDEFGHIJKLMNOPQRSTUVWXYZOthers

Research and education only. Not investment advice under SEBI (IA) Regulations 2013, not a research report under SEBI (RA) Regulations 2014. Not a SEBI-registered Adviser, Analyst, or distributor.

AskNivesh©2026
asknivesh.com
← Back to APLLTD

ALEMBIC PHARMACEUTICALS LIMITED: Detailed financials

Line items extracted directly from the company's NSE-filed XBRL. Click + to expand subtotals. Click any row to chart it. All values in ₹ crore.

ParticularsMar-25Jun-25Sep-25Dec-25Mar-26
Revenue
1,7701,7111,9101,8761,848
Other income
14771626
Expenses
1,5911,5271,6951,6861,731
Cost of materials consumed
426431463449404
Purchases of stock-in-trade
93109127143130
Change in inventories
12-133-74-63-2
Employee benefit expense
394423438433439
Finance costs
2524242323
Depreciation & amortisation
6974768089
Other expenses
574599641621649
EBITDA
287288322266229
EBIT
218215246186141
Exceptional items
----42-25
Profit Before Tax
193191222163118
Tax expense
35374030-83
Deferred tax
1514-72-114
Net Profit
157154184132202
Financial Ratios
Operating Profit Margin
12.29%12.54%12.89%9.93%7.61%
EBITDA Margin
16.19%16.85%16.87%14.20%12.40%
Net Profit Margin
8.87%9.00%9.63%7.04%10.93%
Earnings Per Share (₹)
7.987.859.406.7610.31

Revenue

₹ in crore

Click any row in the table to chart it here.

Source: NSE integrated filing results & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Ratios (operating margin, net margin) and EBITDA / EBIT / FCF / shareholders' funds are computed from the filed line items.